Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Membranous Glomerulonephritis”

159 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 159 results

Post-approval studies (Phase 4)WithdrawnNCT01926054
What this trial is testing

ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

Who this might be right for
SLE Glomerulonephritis Syndrome, WHO Class V
Ohio State University
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Not applicableLooking for participantsNCT06242327
What this trial is testing

An Outcome Analysis of Primary Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 500
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Not applicableStudy completedNCT00983034
What this trial is testing

The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy

Who this might be right for
Nephrotic SyndromeGlomerulonephritisMembranous Nephropathy
Istanbul University 70
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Testing effectiveness (Phase 2)Study completedNCT00694863
What this trial is testing

Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT00977977
What this trial is testing

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Who this might be right for
Nephrotic SyndromeProteinuriaAutoimmune Disease+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 30
Post-approval studies (Phase 4)Ended earlyNCT01129557
What this trial is testing

Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

Who this might be right for
Proteinuric Kidney DiseaseDiabetic NephropathyHypertensive Nephrosclerosis+4 more
Columbia University 46
Large-scale testing (Phase 3)Study completedNCT00135967
What this trial is testing

Mycophenolate Mofetil in Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT04456816
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

Who this might be right for
Nephrotic Syndrome Due to Idiopathic Membranous NephropathySevere Proteinuria Due to Idiopathic Membranous Nephropathy
SynAct Pharma Aps 23
Testing effectiveness (Phase 2)Ended earlyNCT04652570
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Tenet Medicines 6
Post-approval studies (Phase 4)Looking for participantsNCT07404436
What this trial is testing

Rivaroxaban in Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Beijing Friendship Hospital 134
Large-scale testing (Phase 3)Study completedNCT00362531
What this trial is testing

Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome

Who this might be right for
Idiopathic Membranous NephropathyNephrotic Syndrome
Peking University
Very early researchNot Yet RecruitingNCT07423572
What this trial is testing

Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)

Who this might be right for
Refractory Idiopathic Membranous Nephropathy
The First Affiliated Hospital of Zhejiang Chinese Medical University 18
Very early researchNot Yet RecruitingNCT07535138
What this trial is testing

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)IgA Nephropathy (IgAN)
Air Force Military Medical University, China 15
Not applicableWithdrawnNCT01093781
What this trial is testing

Aliskiren in Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Mayo Clinic
Large-scale testing (Phase 3)Active Not RecruitingNCT05707377
What this trial is testing

Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
BeOne Medicines 178
Early research (Phase 1)Looking for participantsNCT06982729
What this trial is testing

Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06614985
What this trial is testing

The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Renmin Hospital of Wuhan University 172
Load More Results